AR041602A1 - Identificacion y tratamiento de infecciones vaginales - Google Patents

Identificacion y tratamiento de infecciones vaginales

Info

Publication number
AR041602A1
AR041602A1 ARP030103727A ARP030103727A AR041602A1 AR 041602 A1 AR041602 A1 AR 041602A1 AR P030103727 A ARP030103727 A AR P030103727A AR P030103727 A ARP030103727 A AR P030103727A AR 041602 A1 AR041602 A1 AR 041602A1
Authority
AR
Argentina
Prior art keywords
identification
vaginal
treatment
vaginal infections
treat
Prior art date
Application number
ARP030103727A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Vsl Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsl Pharmaceuticals Inc filed Critical Vsl Pharmaceuticals Inc
Publication of AR041602A1 publication Critical patent/AR041602A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presencia de una afección vaginal es determinada en una paciente usando un indicador identificable y, si la identificación es positiva, se administra localmente una composición ginecológica que comprende una o más cepas de Lactobacillus en una cantidad efectiva para tratar la afección vaginal. También se describen envases o kits que incluyen un elemento de exploración o herramienta, tal como un guante que tiene una sustancia indicadora para indicar la presencia de una infección vaginal, envasada junto con una composición ginecológica para tratar la infección vaginal, si se determina su presencia.
ARP030103727A 2002-10-15 2003-10-14 Identificacion y tratamiento de infecciones vaginales AR041602A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/270,167 US20040071679A1 (en) 2002-10-15 2002-10-15 Identifying and treating vaginal infections

Publications (1)

Publication Number Publication Date
AR041602A1 true AR041602A1 (es) 2005-05-26

Family

ID=32068930

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103727A AR041602A1 (es) 2002-10-15 2003-10-14 Identificacion y tratamiento de infecciones vaginales

Country Status (4)

Country Link
US (2) US20040071679A1 (es)
AR (1) AR041602A1 (es)
AU (1) AU2003279526A1 (es)
WO (1) WO2004035072A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
ATE289514T1 (de) * 2003-11-03 2005-03-15 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
US20050239742A1 (en) * 2004-04-08 2005-10-27 Vivus, Inc. Carrageenan-based formulations and associated methods of use
WO2006045347A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
AU2004326300B2 (en) * 2004-12-23 2012-03-01 Actial Farmaceutica Lda. Device and method for identifying and treating vaginal affections
CA2599909C (en) * 2005-03-03 2014-12-02 Meiji Dairies Corporation Immune function modulating agents
ITMI20061421A1 (it) * 2006-07-20 2008-01-21 Velleja Res Srl Composizioni farmaceutiche topiche vaginali
US8642029B2 (en) * 2008-03-31 2014-02-04 Osel, Inc. Transiently buffered Lactobacillus preparations and use thereof
ITMI20080949A1 (it) * 2008-05-22 2009-11-23 Sinclair Pharma Srl Nuovo ceppo del genere lactobacillus e formulazioni farmaceutiche topiche che lo contengono
JP4942831B2 (ja) * 2010-03-19 2012-05-30 株式会社キティー 抗アレルギー用組成物
EP2596797B1 (en) * 2011-11-23 2015-10-21 Biolatte Oy A vaginal capsule
US8663177B1 (en) * 2012-09-28 2014-03-04 Anal-Gesic LLC Medication delivery, dosing and safety devices, systems and kits
MX2016014991A (es) * 2014-05-16 2017-09-11 Pizeta Group Srl Composiciones que contienen acido borico y una mezcla de lactobacilos.
BE1023643B1 (nl) 2016-03-21 2017-06-01 Yun NV Vaginale preparaten voor het onderhouden en / of herstellen van een gezonde vrouwelijke microbiota
AU2017368922A1 (en) * 2016-11-30 2019-05-30 Probioswiss Ag Urogenital medical device formulation based on suitable biochemical compositions for the stabilization of the acidity and the redox state of the vaginal fluid
CN107299065B (zh) * 2017-06-20 2020-02-14 广东强基药业有限公司 一种植物乳杆菌及其用于制备阴道抑菌药物的应用
CN109464655B (zh) * 2019-01-08 2021-08-13 福建龙生生物科技有限公司 一种防治阴道炎的外用胶囊制剂
CN111281896B (zh) * 2020-02-14 2020-11-03 昆明加加宁生物制品有限公司 一种调节妇科微生态平衡的复合菌剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
EP0556685A3 (en) * 1992-02-20 1993-09-29 Miles Inc. Diagnosis of trichomonas vaginitis by detecting formate in vaginal fluid
US5823953A (en) * 1996-06-20 1998-10-20 Roskin; Amy C. Secretion analysis apparatus and method
US5660790A (en) * 1996-08-13 1997-08-26 Litmus Concepts, Inc. PH and amine test elements
PT956858E (pt) * 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US6479045B2 (en) * 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
DE19963104A1 (de) * 1999-12-24 2001-06-28 Ralf Kirkamm Mittel zur Behandlung von Bakterienmangel
IL143810A (en) * 2001-06-18 2008-06-05 Alexander Schoenfeld Prophylactic article useful for both protection and diagnosis and method for use and production thereof

Also Published As

Publication number Publication date
AU2003279526A1 (en) 2004-05-04
WO2004035072A3 (en) 2004-07-08
WO2004035072A2 (en) 2004-04-29
US20060057132A1 (en) 2006-03-16
US20040071679A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AR041602A1 (es) Identificacion y tratamiento de infecciones vaginales
AR055827A1 (es) Un dispositivo y un metodo para usar dicho dispositivo para el diagnostico de afecciones vaginales
CY1118059T1 (el) Συνθεσεις αντιλοιμωδων βασει λιπιδιων για αγωγη πνευμονικων λοιμωξεων
CR6008A (es) Un articulo absorbente envuelto individualmente
ATE514402T1 (de) Komponente zur bildung eines siegels um eine hautöffnung
AR048791A1 (es) Tampon con paneles flexibles
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
BRPI0211282B8 (pt) curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador
BRPI0509053A (pt) composição farmacêutica anidra e uso de um agente siliconado e de uma composição
CY1106319T1 (el) Τοπικη θepαπεια στη μασταλγια
BR0313739A (pt) Método para minimizar a possibilidade de resultados falso-positivos e falso-negativos na detecção de pequenas quantidades de lìquido amniótico em secreção vaginal e dispositivo para realizar o método
AR036652A1 (es) Composiciones para el tratamiento del cabello que brindan cuerpo al cabello y que comprenden adhesivos sensibles a la presion de la silicona
Herbst et al. Bactericidal efficacy of cold plasma at different depths of infected root canals in vitro
CY1106227T1 (el) Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
DE502004011851D1 (de) Caspase 3, 8, 9 oder 10 Inhibitoren in Kombination mit MEK Inhibitoren zur Behandlung von Influenza
BR112012024107A2 (pt) peça de roupa usável e seu uso na prevenção de estrias.
WO2003007997A3 (en) Secretion-monitoring article
Kutuk et al. Influence of preprocedural antiseptic mouthrinses against COVID-19 on enamel/dentin bond strength of a universal adhesive
CN204446298U (zh) 一种包皮手术的术后恢复辅助装置
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
AR034384A1 (es) Un articulo absorbente
Ojha et al. “Missed Band Under the Band”: Don’t Miss it!
CN204601371U (zh) 一种便携式止血消毒棉球

Legal Events

Date Code Title Description
FB Suspension of granting procedure